The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis.

Autor: Sternby H; Section for Surgery, Department of Clinical Sciences, Malmö, Lund University, Skane University Hospital, 20502 Malmö, Sweden., Hartman H; Section for Surgery, Department of Clinical Sciences, Malmö, Lund University, Skane University Hospital, 20502 Malmö, Sweden., Thorlacius H; Section for Surgery, Department of Clinical Sciences, Malmö, Lund University, Skane University Hospital, 20502 Malmö, Sweden., Regnér S; Section for Surgery, Department of Clinical Sciences, Malmö, Lund University, Skane University Hospital, 20502 Malmö, Sweden.
Jazyk: angličtina
Zdroj: Biomolecules [Biomolecules] 2021 Apr 17; Vol. 11 (4). Date of Electronic Publication: 2021 Apr 17.
DOI: 10.3390/biom11040591
Abstrakt: Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0-24 and 25-48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0-24 and 25-48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 ( p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low.
Databáze: MEDLINE